ArticleBMC nephrology2025

High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case report.

Akhtar Ashfaq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.